UCB banks on Georgia for $2bn biologics manufacturing facility

UCB has chosen Georgia as the home for its new biologics manufacturing facility, cementing its legacy in the state and marking the company’s latest expansion effort in the key US market. The $2bn, 460,000 ft², digital-first site, located in Gwinnett County’s Rowen Development, will be the “cornerstone” of UCB’s global biologics manufacturing infrastructure – operating 24/7 once in action to supply the US market. When the facility is up and running, it will employ around 330 skilled staff, while generati ...